$Evaxion Biotech (EVAX.US)$ Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package Tuesday, 25th February at 8:00 am Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data The additional third year of EVX-01 dosing may provide further insights into potential enhanced treatment effects and durability of induced immune response The trial already yielded convin...
$Evaxion Biotech (EVAX.US)$Reuters· just Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine Evx-01 to Further Enhance Clinical Data Package
Evaxion Biotech Stock Forum
Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package
Tuesday, 25th February at 8:00 am
Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data
The additional third year of EVX-01 dosing may provide further insights into potential enhanced treatment effects and durability of induced immune response
The trial already yielded convin...
Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine Evx-01 to Further Enhance Clinical Data Package
Financial Turnaround: Evaxion Secures Future with $17M Raise, Dodges Delisting
Nasdaq Confirms Evaxion Is Fully Compliant, Withdraws Delisting Determination
No comment yet